Benzinga | Oct 6, 2021 08:35AM EDT

PDS Biotechnology Names Matthew Hill As CFO

PDS Biotechnology Corporation (NASDAQ:PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company's proprietary Versamune(r) T-cell activating technology, today announced that Matthew Hill will join PDS Biotech as its Chief Financial Officer (CFO) effective as of October 18, 2021, to lead the company's financial strategy through its next phase of growth.



Mr. Hill brings more than 25 years of experience in finance and operational leadership roles for life science companies. He is joining PDS Biotech after spending the last several years at Strata Skin Sciences (NASDAQ:SSKN) as their Chief Financial Officer, where he led the financial vision and strategy for the medical device company. Prior to joining Strata Skin Sciences, he held CFO roles at several companies, including Velcera prior to its acquisition by the Perrigo Company, and EP Medsystems prior to its acquisition by St. Jude Medical, where he also served as the VP of Operations. Mr. Hill holds a Bachelor of Science in accounting from Lehigh University.

"Given the promise of the Versamune(r) platform in oncology, I'm excited to bring my experience with life science companies to PDS Biotech's next chapter. PDS has achieved significant milestones in the last year and I am energized to contribute my expertise and leadership to direct PDS Biotech's financial strategy to facilitate its next phase of growth," said Hill.

"We are focused on developing and commercializing novel and more effective treatments for cancer," said PDS Biotech President and CEO Dr. Frank Bedu-Addo. "Matt's extensive experience with growth-stage healthcare and life science companies will provide PDS Biotech with solid financial leadership and I look forward to working closely with Matt to fulfill the promise demonstrated thus far of bringing novel oncology products to the market."

Mr. Hill will replace Seth Van Voorhees in the role of CFO. Dr. Bedu-Addo continued, "On behalf of our board of directors, we would like to thank Seth for his service to the company and wish him continued success in his future endeavors."